Repáraz, D.; Aparicio, B.; Llopiz, D.; Hervás-Stubbs, S.; Sarobe, P.
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens? Int. J. Mol. Sci. 2022, 23, 2022.
https://doi.org/10.3390/ijms23042022
AMA Style
Repáraz D, Aparicio B, Llopiz D, Hervás-Stubbs S, Sarobe P.
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens? International Journal of Molecular Sciences. 2022; 23(4):2022.
https://doi.org/10.3390/ijms23042022
Chicago/Turabian Style
Repáraz, David, Belén Aparicio, Diana Llopiz, Sandra Hervás-Stubbs, and Pablo Sarobe.
2022. "Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?" International Journal of Molecular Sciences 23, no. 4: 2022.
https://doi.org/10.3390/ijms23042022
APA Style
Repáraz, D., Aparicio, B., Llopiz, D., Hervás-Stubbs, S., & Sarobe, P.
(2022). Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens? International Journal of Molecular Sciences, 23(4), 2022.
https://doi.org/10.3390/ijms23042022